Growth Metrics

Lucid Diagnostics (LUCD) Total Current Liabilities (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Total Current Liabilities readings, the most recent being $28.6 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 21.5% to $28.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.6 million, a 21.5% increase, with the full-year FY2025 number at $28.6 million, up 21.5% from a year prior.
  • Total Current Liabilities hit $28.6 million in Q4 2025 for Lucid Diagnostics, up from $26.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $36.6 million in Q1 2025 to a low of $4.3 million in Q4 2021.
  • Median Total Current Liabilities over the past 5 years was $23.4 million (2023), compared with a mean of $20.5 million.
  • Biggest five-year swings in Total Current Liabilities: surged 248.75% in 2023 and later plummeted 52.86% in 2024.
  • Lucid Diagnostics' Total Current Liabilities stood at $4.3 million in 2021, then skyrocketed by 97.77% to $8.4 million in 2022, then surged by 248.75% to $29.4 million in 2023, then decreased by 19.94% to $23.5 million in 2024, then increased by 21.5% to $28.6 million in 2025.
  • The last three reported values for Total Current Liabilities were $28.6 million (Q4 2025), $26.2 million (Q3 2025), and $29.4 million (Q2 2025) per Business Quant data.